|
⚲
|
| Keyboard |
| Lee Tien-LI
✚
|
|
|---|---|
| CIK # | 0001940120 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001940120] | |
| 4 | [0001940120] | |
| SC 13G | [0001940120] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Lee Tien-LI | Aardvark Therapeutics Inc | [2025-05-15] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Aardvark Therapeutics Inc | |
| Lee Tien-LI | |
| Scilex Holding Co |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aardvark Therapeutics Inc AARD
Stock option (right to buy) · derivative
|
2026-02-09 | Grant | 203,851 | $0.00 | |
|
Aardvark Therapeutics Inc AARD
Common Stock
|
2025-12-11 | Buy | 7,000 | $14.49 | 101,430 |
|
Aardvark Therapeutics Inc AARD
Common Stock
|
2025-10-15 | Option exercise | 1,229 | $4.24 | 5,211 |
|
Aardvark Therapeutics Inc AARD
Stock option (right to buy) · derivative
|
2025-10-15 | Option exercise | 1,229 | $0.00 | |
|
Aardvark Therapeutics Inc AARD
Stock option (right to buy) · derivative
|
2025-06-11 | Grant | 549,534 | $0.00 | |
|
Aardvark Therapeutics Inc AARD
Series A Convertible Preferred Stock · derivative
|
2025-02-14 | Conversion | 350,002 | $0.00 | |
|
Aardvark Therapeutics Inc AARD
Common Stock
|
2025-02-14 | Conversion | 41,303 | ||
|
Aardvark Therapeutics Inc AARD
Common Stock
|
2025-02-14 | Buy | 16,542 | $16.00 | 264,672 |
|
Scilex Holding Co SCLX
Nonstatutory Stock Option (right to buy) · derivative
|
2023-01-17 | Grant | 250,000 | $0.00 |